基于化学遗传学筛选产萘醌类化合物内生放线菌

【目的】为探究含具有抗肿瘤活性的美登素的滑桃(Trewia nudiflora)种子中内生放线菌的多样性,以及从内生放线菌中寻找萘醌类化合物产生菌。【方法】利用放线菌富集筛选培养基对经消毒处理的滑桃种子进行内生菌分离,根据菌落形态及16S rRNA基因序列分析进行菌种的分类鉴定。通过对所分离到的内生放线菌拮抗模式病原细菌(金黄色葡萄球菌、铜绿假单胞菌)、作物病原真菌(小麦赤霉菌、水稻纹枯病致病菌等)活性检测,以及萘醌类化合物合成关键基因为探针定向筛选萘醌类化合物产生菌。【结果】从分离到的100余株滑桃种子内生菌中鉴定出66株以链霉菌为主的放线菌,发现Streptomyces sp.HTZ27菌株含有目标基因,经固体发酵、化合物分离纯化、鉴定后,发现该菌发酵产物中有呋喃萘醌I,得率接近5 mg/L。【意义】本研究采用的化学遗传学方法可有效提高筛选目标化合物产生菌的效率,所筛选到FNQ I产生菌为深入研究呋喃萘醌类化合物生物合成与调控、抗肿瘤分子机理以及产业化应用等创建了有利条件。     

链霉菌CB02959中四霉素及四烯菌素的鉴定及培养基优化

【背景】四霉素(Tetramycin)和四烯菌素(Tetrin)是具有广谱抗真菌活性的四烯大环内酯类抗生素。链霉菌CB02959是一株雷纳霉素(Leinamycin)类化合物的潜在产生菌株,利用antiSMASH分析其基因组发现该菌株含有一个纳他霉素(Natamycin)类四烯大环内酯化合物的生物合成基因簇。【目的】对Streptomyces sp. CB02959中次级代谢产物进行研究,确定其是否可以产生四烯大环内酯化合物,对其发酵产物进行分离和结构鉴定,并进行初步的发酵优化以提高产量。【方法】基于生物信息学预测和高分辨质谱数据,推测CB02959中多烯化合物的结构;在不同发酵培养基中培养CB02959,确定适合大规模发酵的培养基;敲除tetrA基因以确定目标基因簇和四烯大环内酯化合物产生的相关性;分离和鉴定CB02959产生的主要代谢物的结构;通过改变培养基中葡萄糖、麦芽提取物和胰蛋白胨的含量,提高四烯大环内酯化合物的产量。【结果】通过对CB02959中纳他霉素类化合物生物合成基因簇的分析及16S rRNA基因序列的进化树分析,推测CB02959可能是一株新的四霉素和四烯菌素产生菌;在YEME发酵培养基中对CB02959进行大规模发酵,分离得到4个化合物,鉴定为四霉素A (1)、四霉素B (2)、四烯菌素A (3)、四烯菌素B (4);最后通过培养基的初步优化,将化合物1–4的产量分别提高至208.1、100.0、1 315.6、109.9 mg/L。【结论】通过基因组挖掘策略发现了一株新的四霉素和四烯菌素产生菌链霉菌CB02959,并通过培养基优化提升了其四烯大环内酯化合物的产量,此发现为这类抗真菌天然产物的后续开发奠定了基础。     

北极海洋链霉菌604F的卤化酶基因克隆及特征

【目的】本研究旨在克隆来自北极海洋、具有合成卤化物潜力的链霉菌(Streptomyces sp.)604F中的一个卤化酶基因,为后续克隆卤化物合成基因簇、分离鉴定卤化物提供指导。【方法】利用琼脂块法初步测试抗菌活性,借助液相色谱-飞行时间串联质谱技术(LC-Tof MS)初步寻找Streptomyces sp.604F发酵粗提液中的卤化物,并以简并PCR扩增合成次级代谢产物的指示基因(I型、II型聚酮合酶及非核糖体多肽合成酶编码基因);根据依赖黄素腺嘌呤二核苷酸的卤化酶基因保守区设计的简并引物,扩增基因片段并测序分析;采用高效热不对称交错PCR(hiTAIL-PCR)技术扩增卤化酶基因全长。【结果】Streptomyces sp.604F具有较强的抗白色念珠菌活性,其基因组同时含有编码I型聚酮合酶、II型聚酮合酶和非核糖体多肽合成酶基因,以及卤化酶基因;通过染色体步移克隆该卤化酶基因全长,共1443 bp,编码一个新的非色氨酸卤化酶,在合成已知卤化物的卤化酶数据库中,与其同源关系最近的为一类参与合成糖肽类次级代谢产物的卤化酶。【结论】Streptomyces sp.604F具有新的非色氨酸卤化酶,且推测参与糖肽类化合物的卤化修饰,为后续寻找目的卤化物提供了指导,也为研究该合成基因簇奠定基础。     

肇庆星湖湿地可培养放线菌多样性

摘要:【目的】探究星湖湿地可培养放线菌物种多样性,筛选潜在药源活性代谢产物产生菌,为后续菌种资源开发奠定基础。【方法】采用5种选择性分离培养基分离星湖湿地底泥中的放线菌,通过16S rRNA基因同源性分析代表性菌株的物种多样性;以3株病原细菌为指示菌检测分离菌株的抑菌活性;PCR扩增代表菌株的聚酮合酶(PKS I、PKS II)基因、非核糖体多肽合成酶(NRPS)基因、安莎类化合物(AHBA)基因及3-羟基-3-甲基戊二酰辅酶A还原酶(HMGA)基因。【结果】分离到135株放线菌菌株,被鉴定为放线菌纲的7 个目、10个科、13个属,优势类群为链霉菌、小单孢菌及诺卡氏菌。83株检测菌中,24.09%抗金黄色葡萄球菌(Staphylococcus aureus),4.8%抗大肠杆菌(Escherichia coli);24株高活性菌株中PKS I阳性率16.7%,PKS II阳性率62.5%,NRPS阳性率16.7%,AHBA阳性率12.5%,HMGA阳性率29.2%。活性复筛及HPLC结果显示,菌株XD007、XD114和XD128显著抑制3株病原指示菌,且能产生大量次级代谢产物。【结论】星湖湿地底泥中放线菌资源丰富,筛选到的活性菌株可用于后续药源活性次级代谢产物的分离。     

伞形酮产生菌的构建

【背景】伞形酮为香豆素类化合物,具有较广泛的药用价值,也是重要的工业制品原料。传统的植物提取成本较高,应开发更有效的获取技术。【目的】利用微生物为宿主异源合成伞形酮。【方法】对不同植物来源香豆素类化合物合成基因进行整合;以酿酒酵母为宿主,通过对宿主酪氨酸代谢通路的改造构建表达宿主,进一步将表达基因转化到改造后的宿主中。【结果】获得产伞形酮的酵母菌株,产量为(67.39±4.87)μg/mL。【结论】通过整合生物合成基因可获得香豆素类天然产物表达菌株。     

番茄溃疡病菌拮抗菌株Z-L-22的鉴定及其活性物质

摘要：【目的】鉴定一株对番茄溃疡病病原菌—密执安棒形杆菌密执安亚种(Clavibacter michiganensis subsp. michiganensis,Cmm)具有强拮抗作用的放线菌菌株Z-L-22,并分析其代谢产物,为开发新的生物活性物质奠定基础。【方法】根据菌株Z-L-22的形态特征、培养特征、生理生化特征、细胞壁组分和16S rDNA序列对菌株Z-L-22的进行了鉴定。通过薄层层析、纸层析和特征性鉴别试验对活性物质进行分离、回收和鉴定。并利用抗生素合成基因保守区域设计的引物用对基因组DNA进行PCR扩增。【结果】菌株Z-L-22属于链霉菌属,各特征与西唐链霉菌(Streptomyces setonii)相似。获得了2个主要活性成分,均为放线菌素类抗生素。利用放线菌素类抗生素合成酶保守引物在该菌基因组中扩增到770 bp的相关基因片段。【结论】活性菌株Z-L-22鉴定为西唐链霉菌,命名为西唐链霉菌Z-L-22。该菌产生的抗生活性物质为放线菌素类抗生素,本研究为开发该菌株奠定基础。     

百部内生放线菌的分离、分类及次级代谢潜力

【目的】以对叶百部块根为材料分离内生放线菌,并对分离菌株进行分类、抗菌活性和次级代谢产物合成基因研究。【方法】样品经过严格的表面消毒,选用4种培养基分离百部内生放线菌;分离菌株通过形态观察和16S rRNA序列分析进行分类鉴定;采用琼脂移块法测试分离菌株的抗菌活性;通过PCR检测分离菌株的PKS/NPRS和卤化酶基因;使用HPLC-UV/VIS-ESI-MS/MS分析发酵产物。【结果】从6个样品中获得18株内生放线菌,分属链霉菌属(Streptomyces)、小单孢菌属(Micromonospora)、假诺卡氏菌属(Pseudonocardia)和甲基杆菌属(Methylobacterium)。分离菌株绝大部分具有抗菌活性和次级代谢产物合成基因,其中13株对耐药金黄色葡萄球菌和/或绿脓杆菌有拮抗活性,17株具有PKS/NRPS基因,8株菌具有卤化酶基因,且卤化酶阳性代表菌株的发酵产物具有抗细菌活性和卤代化合物特征。【结论】百部作为一种传统中药,其内生放线菌以链霉菌和小单孢菌为主,在次级代谢产物合成方面具有很好的潜力,可作为一类重要微生物资源进行活性产物开发。     

一株盐湖芽孢杆菌LG的鉴定及其抗金黄色葡萄球菌活性研究

【目的】从运城盐湖中分离获得一株耐盐细菌LG,对其进行分类鉴定及抗菌特性研究。【方法】利用16S rRNA基因序列分析对菌株进行分类鉴定。以金黄色葡萄球菌为指示菌,采用杯碟法对菌株LG发酵上清液进行抗菌活性检测,利用扫描电镜和透射电镜观察其抗菌效果。研究不同因素对上清液抗菌活性的影响,并采用PCR技术对菌株基因组进行功能基因筛查。【结果】系统发育分析表明该菌为Bacillus属成员,在0–25%的NaCl浓度范围内生长良好,为耐盐细菌。电镜观察发现,菌株LG发酵上清液处理金黄色葡萄球菌可导致细胞结构明显出现异常,细胞质泄漏。抗菌稳定性研究表明,菌株LG发酵上清液活性稳定,表现出了良好的对紫外光、温度、pH和NaCl的耐受性。采用特异性引物,通过PCR筛查发现菌株LG基因组中含有聚酮合酶(PKS I)基因和非核糖体肽合成酶(NRPS)基因,表明该菌具有产多种代谢产物的潜力。【结论】极端环境中的微生物资源可作为抗菌活性物质的潜在新来源。     

化学诱导对一株海洋来源土曲霉C23-3次生代谢产物及其生物活性的影响

【背景】海洋微生物是药理活性先导化合物的重要源泉,而化学诱导是深入挖掘其次生代谢潜力的一种便捷手段。【目的】以一株海洋来源土曲霉C23-3为出发菌株,筛选出可促进其产生更丰富代谢产物(包括丁内酯类化合物)的发酵条件,进一步开发菌株在抗阿尔茨海默症方面的潜力。【方法】分别选用海水马铃薯培养基、麦芽浸膏培养基、大米培养基和大豆培养基4种基础培养基,利用丁酸钠、辛二酰苯胺异羟肟酸(Suberoylanilidehydroxamicacid,SAHA)、5-氮杂胞嘧啶核苷(5-azacytidine,5-azaC)、盐酸普鲁卡因(Procaine hydrochloride)、ZnCl_2和CuCl_2共6种化学诱导剂对土曲霉C23-3进行微量的诱导培养。观察该菌菌丝体形态变化,并根据薄层层析(Thin-layerchromatography,TLC)指纹图谱、化学显色及生物活性自显影结果初筛出代谢产物丰富且乙酰胆碱酯酶抑制活性与抗氧化活性产物丰富的诱导条件,并进行进一步常量发酵。采用上述手段及高效液相色谱-二极管阵列检测器(High performance liquid chromatography-Diode array detector,HPLC-DAD)分析常量发酵代谢产物的总体多样性及丁内酯类化合物的多样性。【结果】发现CuCl_2、ZnCl_2、SAHA和5-azaC可引起土曲霉C23-3菌丝体生长形态显著变化,海水马铃薯培养基+100μmol/L丁酸钠等6种诱导条件在微量培养初筛及常量发酵复筛中均可使该菌株产生多样化的活性代谢产物,其丁内酯类代谢产物也具有一定差异性。【结论】化学诱导手段可促使土曲霉C23-3产生丰富且新颖的活性代谢产物,为多样化的抗阿尔茨海默症天然产物的发现奠定了基础。     

不同生境放线菌的卤化酶基因分析及其对卤代产物筛选的意义

摘要：【目的】在基因水平上分析并比较陆地来源与海洋来源的放线菌产生卤化代谢产物的潜力。【方法】基于依赖黄素腺嘌呤二核苷酸的卤化酶基因筛选,从经过表型去重复的70株陆地来源和71株海洋来源的放线菌中,通过PCR筛选获得卤化酶基因片段,并进行测序鉴定;通过卤化酶氨基酸序列的系统发育分析,比较不同来源放线菌的卤化酶序列,以及海洋链霉菌和小单孢菌的卤化酶序列。另外,对卤化酶阳性菌株进行了聚酮合酶和非核糖体多肽合成酶基因的检测。【结果】本研究中36.6%的海洋放线菌具有卤化酶基因,其阳性率远高于本研究所涉及的陆地放     

Neocarzinostatin naphthoate synthase: an unique iterative type I PKS from neocarzinostatin producer Streptomyces carzinostaticus

Enediyne antibiotics are known for their potent antitumor activities. One such enediyne, neocarzinostatin (NCS), consists of a 1:1 complex of non-peptide chromophore (1a), and peptide apoprotein. The structurally diverse non-peptide chromophore is responsible for its biological activity. One of its structural components, the naphthoic acid moiety (2,7-dihydroxy-5-methyl-1-naphthoic acid, 1d) is synthesized by a polyketide synthase (PKS) pathway through condensing six intact acetate units. The 5.45 kb iterative type I PKS, neocarzinostatin naphthoate synthase (NNS), responsible for naphthoic acid moiety biosynthesis, shares sequence homology with 6-methyl salicylic acid synthase of fungi and orsellinic acid synthases (AviM and CalO5) of Streptomyces origin. Cultures of S. lividans TK24 and S. coelicolor YU105 containing plasmids with NNS were able to produce 2-hydroxy-5-methyl-1-naphthoic acid (2a), a key intermediate of naphthoic acid moiety in NCS. In addition to 2a, a novel product, 2-hydroxy-5-hydroxymethyl-1-naphthoic acid (2d) was isolated. This is the first report of a bacterial iterative type I PKS from an enediyne producer which enables the biosynthesis of bicyclic aromatic compounds.     

PCR screening reveals considerable unexploited biosynthetic potential of ansamycins and a mysterious family of AHBA‐containing natural products in actinomycetes

Aims

Ansamycins are a family of macrolactams that are synthesized by type I polyketide synthase (PKS) using 3‐amino‐5‐hydroxybenzoic acid (AHBA) as the starter unit. Most members of the family have strong antimicrobial, antifungal, anticancer and/or antiviral activities. We aimed to discover new ansamycins and/or other AHBA‐containing natural products from actinobacteria.

Methods and Results

Through PCR screening of AHBA synthase gene, we identified 26 AHBA synthase gene–positive strains from 206 plant‐associated actinomycetes (five positives) and 688 marine‐derived actinomycetes (21 positives), representing a positive ratio of 2·4–3·1%. Twenty‐five ansamycins, including eight new compounds, were isolated from six AHBA synthase gene–positive strains through TLC‐guided fractionations followed by repeated column chromatography. To gain information about those potential ansamycin gene clusters whose products were unknown, seven strains with phylogenetically divergent AHBA synthase genes were subjected to fosmid library construction. Of the seven gene clusters we obtained, three show characteristics for typical ansamycin gene clusters, and other four, from Micromonospora spp., appear to lack the amide synthase gene, which is unusual for ansamycin biosynthesis. The gene composition of these four gene clusters suggests that they are involved in the biosynthesis of a new family of hybrid PK‐NRP compounds containing AHBA substructure.

Conclusions

PCR screening of AHBA synthase is an efficient approach to discover novel ansamycins and other AHBA‐containing natural products.

Significance and Impact of the Study

This work demonstrates that the AHBA‐based screening method is a useful approach for discovering novel ansamycins and other AHBA‐containing natural products from new microbial resources.     

Discovery and characterization of a marine bacterial SAM-dependent chlorinase

Halogen atom incorporation into a scaffold of bioactive compounds often amplifies biological activity, as is the case for the anticancer agent salinosporamide A (1), a chlorinated natural product from the marine bacterium Salinispora tropica. Significant effort in understanding enzymatic chlorination shows that oxidative routes predominate to form reactive electrophilic or radical chlorine species. Here we report the genetic, biochemical and structural characterization of the chlorinase SalL, which halogenates S-adenosyl-L-methionine (2) with chloride to generate 5'-chloro-5'-deoxyadenosine (3) and L-methionine (4) in a rarely observed nucleophilic substitution strategy analogous to that of Streptomyces cattleya fluorinase. Further metabolic tailoring produces a halogenated polyketide synthase substrate specific for salinosporamide A biosynthesis. SalL also accepts bromide and iodide as substrates, but not fluoride. High-resolution crystal structures of SalL and active site mutants complexed with substrates and products support the S(N)2 nucleophilic substitution mechanism and further illuminate halide specificity in this newly discovered halogenase family.     

Diversity of culturable actinobacteria isolated from marine sponge <Emphasis Type="Italic">Haliclona</Emphasis> sp.

This study describes actinobacteria isolated from the marine sponge Haliclona sp. collected in shallow water of the South China Sea. A total of 54 actinobacteria were isolated using media selective for actinobacteria. Species diversity and natural product diversity of isolates from marine sponge Haliclona sp. were analysed. Twenty-four isolates were selected on the basis of their morphology on different media and assigned to the phylum Actinobacteria by a combination of 16S rRNA gene based restriction enzymes digestion and 16S rRNA gene sequence analysis. The 16S rRNA genes of 24 isolates were digested by restriction enzymes TaqI and MspI and assigned to different groups according to their restriction enzyme pattern. The phylogenetic analysis based on 16S rRNA gene sequencing showed that the isolates belonged to the genera Streptomyces, Nocardiopsis, Micromonospora and Verrucosispora; one other isolate was recovered that does not belong to known genera based on its unique 16S rRNA gene sequence. To our knowledge, this is the first report of a bacterium classified as Verrucosispora sp. that has been isolated from a marine sponge. The majority of the strains tested belong to the genus Streptomyces and three isolates may be new species. All of the 24 isolates were screened for genes encoding polyketide synthases (PKS) and nonribosomal peptide synthetases (NRPS). PKS and NRPS sequences were detected in more than half of the isolates and the different "PKS-I-PKS-II-NRPS" combinations in different isolates belonging to the same species are indicators of their potential natural product diversity and divergent genetic evolution.     

水霉拮抗菌的筛选及其拮抗活性物质稳定性初步研究

【目的】从海底沉积物中分离、筛选水霉拮抗放线菌菌株,鉴定目标菌株及其无菌发酵液对水霉生长的抑制效果,并初步分析拮抗活性物质的稳定性。【方法】用稀释涂布法从采集的海底沉积物中分离得到海洋放线菌,以水霉为靶菌,通过平板对峙法在PDA平板上筛选出对水霉有拮抗作用的菌株;利用其发酵液对水霉菌丝和孢子进行初步拮抗效果研究;通过16S rRNA基因序列分析对目标菌株的种属进行初步鉴定。【结果】从分离到的数十株海洋放线菌中筛选到5株水霉拮抗菌,其中拮抗效果最强的为S26菌株,16S rRNA基因序列分析结果显示其为链霉菌,并与紫色链霉菌具有较近的亲缘关系;S26马铃薯葡萄糖液体培养基发酵液在平板抑菌圈实验中,对水霉孢子萌发的抑菌圈直径达32.00 mm±0.81 mm,其5倍浓缩无菌发酵液对水霉菌丝的抑菌圈直径达39.75 mm±0.50 mm;5倍浓缩无菌发酵液抑菌活性的3.125%即能完全抑制水霉孢子的萌发;5倍浓缩液对温度具有较强耐受性,经100 °C高温30 min处理后平板抑菌圈直径为25.50 mm±0.58 mm;经不同pH值处理12 h后,pH 5.0–9.0之间仍保持较好的拮抗活性;在37 °C下蛋白酶处理2 h后实验组与对照组存在显著性差异,但平板抑菌圈直径仍可达33.25 mm以上,推测拮抗物质活性成分由多肽和非多肽类代谢物共同组成。【结论】海洋链霉菌株S26产生的活性物质对病原水霉真菌有较强的抑制作用,并对外界环境变化有较强的适应能力,因而在水霉病的生物防治中具有潜在的应用价值。研究结果同时也显示海洋链霉菌在水产病害生物防治应用领域有较好的发展前景和更广阔的挖掘空间。     

A hydroxylase-like gene product contributes to synthesis of a polyketide spore pigment in Streptomyces halstedii.

A gene, schC, adjacent to the sch gene cluster encoding the biosynthesis of a polyketide spore pigment in Streptomyces halstedii was sequenced. Its deduced product resembled flavin adenine nucleotide-containing hydroxylases involved in the biosynthesis of polycyclic aromatic polyketide antibiotics and in catabolic pathways of aromatic compounds. When schC was disrupted, the normally green spores of S. halstedii became lilac. An schC-like gene was located in an equivalent position next to a large gene cluster (whiE) known to determine spore pigment in Streptomyces coelicolor A3(2).     

除虫链霉菌10个聚酮类抗生素生物合成基因簇的敲除对阿维菌素产量的影响

【目的】考察除虫链霉菌基因组中其它聚酮合成酶类(Polyketide synthase,PKS)抗生素生物合成基因簇的敲除突变对于阿维菌素产量的影响。【方法】构建了11个PKS基因簇的打靶Cosmid和质粒载体,导入除虫链霉菌中筛选突变株。【结果】在工业菌株MMR630中成功敲除了10个PKS基因簇。发酵结果显示7个PKS基因簇敲除突变株中阿维菌素的产量均有不同程度的提高,而2个突变株不能产生阿维菌素。然而,在3个连续敲除2个PKS基因簇的突变株中阿维菌素产量没有能够超过单个PKS敲除突变株的提升幅度。【结论】除虫链霉菌基因组的一些PKS基因簇的敲除可以提高阿维菌素的产量,同时暗示同一类次生代谢产物的代谢流之间存在复杂的相互作用关系。     

Generation of hybrid elloramycin analogs by combinatorial biosynthesis using genes from anthracycline-type and macrolide biosynthetic pathways

Elloramycin and oleandomycin are two polyketide compounds produced by Streptomyces olivaceus Tü2353 and Streptomyces antibioticus ATCC11891, respectively. Elloramycin is an anthracycline-like antitumor drug and oleandomycin a macrolide antibiotic. Expression in S. albus of a cosmid (cos16F4) containing part of the elloramycin biosynthetic gene cluster produced the elloramycin non-glycosylated intermediate 8-demethyl-tetracenomycin C. Several plasmid constructs harboring different gene combinations of L-oleandrose (neutral 2,6-dideoxyhexose attached to the macrolide antibiotic oleandomycin) biosynthetic genes of S. antibioticus that direct the biosynthesis of L-olivose, L-oleandrose and L-rhamnose were coexpressed with cos16F4 in S. albus. Three new hybrid elloramycin analogs were produced by these recombinant strains through combinatorial biosynthesis, containing elloramycinone or 12a-demethyl-elloramycinone (= 8-demethyl-tetracenomycin C) as aglycone moiety encoded by S. olivaceus genes and different sugar moieties, coded by the S. antibioticus genes. Among them is L-olivose, which is here described for the first time as a sugar moiety of a natural product.     

Identification of <Emphasis Type="Italic">mokB</Emphasis> involved in monacolin K biosynthesis in <Emphasis Type="Italic">Monascus pilosus</Emphasis>

Monacolin K (MK), which is widely used as an antihypercholesterolemia medicine, is produced as a fungal secondary metabolite through the polyketide pathway. The MK biosynthetic gene cluster proposed for Monascus pilosus BCRC38072 was also identified in M. pilosus NBRC4480. The mokB gene, located at the end of the putative gene cluster and possibly encoding polyketide synthase, was disrupted. The mokB disruptant did not produce MK, but accumulated an intermediate that was confirmed to be monacolin J, indicating that mokB encodes the polyketide synthase responsible for the biosynthesis of side-chain diketide moiety.